598 JOURNAL OF COSMETIC SCIENCE (31) Y. H. Kang and H. M. Shin, Inhibitory effects of Schizandra chinensis extract on atopic dermatitis in NC/Nga mice, Immunopharmacol. Immunotoxicol., 34(2), 292–298 (2012). (32) S. Y. Shin, J. Lee, H. N. Gil, Y. J. Jung, G. L. Kim, G. H. Kang, and Y. Lim, Schisandra chinensis inhibiting TGFβ-induced activation of hepatic stellate cells, Appl. Biol. Chem., 61(6), 607–616 (2018). (33) H. Yeo, S. S. Ahn, J. Y. Lee, E. Jung, M. Jeong, G. S. Kang, S. Ahn, Y. Lee, D. Koh, Y. H. Lee, Y. Lim, and S. Y. Shin, Disrupting the DNA binding of EGR-1 with a small-molecule inhibitor ameliorates 2,4-dinitrochlorobenzene-induced skin inflammation, J. Invest. Dermatol., 141(7), 1851–1855 (2021). (34) S. Weidinger and N. Novak, Atopic dermatitis, Lancet, 387(10023), 1109–1122 (2016). (35) C. N. Palmer, A. D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, S. P. Lee, D. R. Goudie, A. Sandilands, L. E. Campbell, F. J. Smith, G. M. O’Regan, R. M. Watson, J. E. Cecil, S. J. Bale, J. G. Compton, J. J. DiGiovanna, P. Fleckman, S. Lewis-Jones, G. Arseculeratne, A. Sergeant, C. S. Munro, B. El Houate, K. Mcelreavey, L. B. Halkjaer, H. Bisgaard, S. Mukhopadhyay, and W. H. McLean, Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis, Nat. Genet., 38(4), 441–446 (2006). (36) B. A. Dale, K. A. Resing, and J. D. Lonsdale-Eccles, Filaggrin: a keratin filament associated protein, Ann. N. Y. Acad. Sci., 455, 330–342 (1985). (37) C. R. Harding, S. Aho, and C. A. Bosko, Filaggrin - revisited, Int. J. Cosmet. Sci., 35(5), 412–423 (2013). (38) S. Kezic, P. M. Kemperman, E. S. Koster, C. M. de Jongh, H. B. Thio, L. E. Campbell, A. D. Irvine, W. H. McLean, G. J. Puppels, and P. J. Caspers, Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum, J. Invest. Dermatol., 128(8), 2117–2119 (2008). (39) J. M. Jungersted, H. Scheer, M. Mempel, H. Baurecht, L. Cifuentes, J. K. Høgh, L. I. Hellgren, G. B. Jemec, T. Agner, and S. Weidinger, Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema, Allergy, 65(7), 911–918 (2010). (40) M. C. Winge, T. Hoppe, B. Berne, A. Vahlquist, M. Nordenskjöld, M. Bradley, and H. Törmä, Filaggrin genotype determines functional and molecular alterations in skin of patients with atopic dermatitis and ichthyosis vulgaris, PLOS ONE, 6(12), e28254 (2011). (41) G. Yosipovitch, L. Misery, E. Proksch, M. Metz, S. Ständer, and M. Schmelz, Skin barrier damage and itch: review of mechanisms, topical management and future directions, Acta Derm. Venereol., 99(13), 1201–1209 (2019). (42) M. Hvid, C. Vestergaard, K. Kemp, G. B. Christensen, B. Deleuran, and M. Deleuran, IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction?, J. Invest. Dermatol., 131(1), 150–157 (2011). (43) K. Boniface, F. X. Bernard, M. Garcia, A. L. Gurney, J. C. Lecron, and F. Morel, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes, J. Immunol., 174(6), 3695–3702 (2005). (44) F. Wang and B. S. Kim, Itch: a paradigm of neuroimmune crosstalk, Immunity, 52(5), 753–766 (2020). (45) L. K. Oetjen, M. R. Mack, J. Feng, T. M. Whelan, H. Niu, C. J. Guo, S. Chen, A. M. Trier, A. Z. Xu, S. V. Tripathi, J. Luo, X. Gao, L. Yang, S. L. Hamilton, P. L. Wang, J. R. Brestoff, M. L. Council, R. Brasington, A. Schaffer, F. Brombacher, C. S. Hsieh, R. W. T. Gereau, M. J. Miller, Z. F. Chen, H. Hu, S. Davidson, Q. Liu, and B. S. Kim, Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch, Cell, 171(1), 217–228.e13 (2017). (46) L. S. Wong, T. Wu, and C. H. Lee, Inflammatory and noninflammatory itch: implications in pathophysiology-directed treatments, Int. J. Mol. Sci., 18(7), 1485 (2017). (47) F. Cevikbas, X. Wang, T. Akiyama, C. Kempkes, T. Savinko, A. Antal, G. Kukova, T. Buhl, A. Ikoma, J. Buddenkotte, V. Soumelis, M. Feld, H. Alenius, S. R. Dillon, E. Carstens, B. Homey, A. Basbaum, and M. Steinhoff, A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1, J. Allergy Clin. Immunol., 133(2), 448–460 (2014). (48) D. Green and X. Dong, The cell biology of acute itch, J. Cell Biol., 213(2), 155–161 (2016). (49) T. Takai, TSLP expression: cellular sources, triggers, and regulatory mechanisms, Allergol. Int., 61(1), 3–17 (2012). (50) S. F. Ziegler, Thymic stromal lymphopoietin and allergic disease, J. Allergy Clin. Immunol., 130(4), 845– 852 (2012). (51) J. M. Leyva-Castillo, P. Hener, P. Michea, H. Karasuyama, S. Chan, V. Soumelis, and M. Li, Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade, Nat. Commun., 4, 2847 (2013).

599 SUPPRESSION OF ITCHING BY THREE HERBAL ETHANOLIC EXTRACTS (52) S. R. Wilson, L. Thé, L. M. Batia, K. Beattie, G. E. Katibah, S. P. McClain, M. Pellegrino, D. M. Estandian, and D. M. Bautista, The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch, Cell, 155(2), 285–295 (2013). (53) E. Harno, T. Gali Ramamoorthy, A. P. Coll, and A. White, POMC: the physiological power of hormone processing, Physiol. Rev., 98(4), 2381–2430 (2018). (54) M. Peciña, J. F. Karp, S. Mathew, M. S. Todtenkopf, E. W. Ehrich, and J. K. Zubieta, Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches, Mol. Psychiatry, 24(4), 576–587 (2019). (55) M. Tominaga, H. Ogawa, and K. Takamori, Possible roles of epidermal opioid systems in pruritus of atopic dermatitis, J. Invest. Dermatol., 127(9), 2228–2235 (2007). (56) W. Wang, D. Y. Guo, Y. J. Lin, and Y. X. Tao, Melanocortin regulation of inflammation, Front. Endocrinol., 10, 683 (2019). (57) D. G. Smyth, 60 years of POMC: lipotropin and beta-endorphin: a perspective, J. Mol. Endocrinol., 56(4), T13–25 (2016).